Ad is loading...
PHIO
Price
$2.21
Change
-$0.02 (-0.90%)
Updated
Nov 15 closing price
TPST
Price
$0.89
Change
-$0.08 (-8.25%)
Updated
Nov 15 closing price
122 days until earnings call
Ad is loading...

PHIO vs TPST

Header iconPHIO vs TPST Comparison
Open Charts PHIO vs TPSTBanner chart's image
Phio Pharmaceuticals
Price$2.21
Change-$0.02 (-0.90%)
Volume$51.03K
CapitalizationN/A
Tempest Therapeutics
Price$0.89
Change-$0.08 (-8.25%)
Volume$3.42M
CapitalizationN/A
PHIO vs TPST Comparison Chart
Loading...
PHIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TPST
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
PHIO vs. TPST commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHIO is a Sell and TPST is a StrongSell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (PHIO: $2.21 vs. TPST: $0.89)
Brand notoriety: PHIO and TPST are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PHIO: 64% vs. TPST: 84%
Market capitalization -- PHIO: $1.9M vs. TPST: $38.84M
PHIO [@Biotechnology] is valued at $1.9M. TPST’s [@Biotechnology] market capitalization is $38.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PHIO’s FA Score shows that 0 FA rating(s) are green whileTPST’s FA Score has 0 green FA rating(s).

  • PHIO’s FA Score: 0 green, 5 red.
  • TPST’s FA Score: 0 green, 5 red.
According to our system of comparison, both PHIO and TPST are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PHIO’s TA Score shows that 4 TA indicator(s) are bullish while TPST’s TA Score has 5 bullish TA indicator(s).

  • PHIO’s TA Score: 4 bullish, 6 bearish.
  • TPST’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, TPST is a better buy in the short-term than PHIO.

Price Growth

PHIO (@Biotechnology) experienced а -25.08% price change this week, while TPST (@Biotechnology) price change was -18.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

PHIO is expected to report earnings on May 11, 2023.

TPST is expected to report earnings on Mar 19, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TPST($38.8M) has a higher market cap than PHIO($1.9M). PHIO YTD gains are higher at: -67.690 vs. TPST (-79.775). PHIO has higher annual earnings (EBITDA): -8.55M vs. TPST (-29.84M). TPST has more cash in the bank: 31.1M vs. PHIO (4.7M). PHIO has less debt than TPST: PHIO (0) vs TPST (20.3M). PHIO (0) and TPST (0) have equivalent revenues.
PHIOTPSTPHIO / TPST
Capitalization1.9M38.8M5%
EBITDA-8.55M-29.84M29%
Gain YTD-67.690-79.77585%
P/E Ratio0.01N/A-
Revenue00-
Total Cash4.7M31.1M15%
Total Debt020.3M-
FUNDAMENTALS RATINGS
PHIO vs TPST: Fundamental Ratings
PHIO
TPST
OUTLOOK RATING
1..100
8537
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
55
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9799
PRICE GROWTH RATING
1..100
9594
P/E GROWTH RATING
1..100
7691
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TPST's Valuation (55) in the Pharmaceuticals Major industry is in the same range as PHIO (59) in the Biotechnology industry. This means that TPST’s stock grew similarly to PHIO’s over the last 12 months.

TPST's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as PHIO (100) in the Biotechnology industry. This means that TPST’s stock grew similarly to PHIO’s over the last 12 months.

PHIO's SMR Rating (97) in the Biotechnology industry is in the same range as TPST (99) in the Pharmaceuticals Major industry. This means that PHIO’s stock grew similarly to TPST’s over the last 12 months.

TPST's Price Growth Rating (94) in the Pharmaceuticals Major industry is in the same range as PHIO (95) in the Biotechnology industry. This means that TPST’s stock grew similarly to PHIO’s over the last 12 months.

PHIO's P/E Growth Rating (76) in the Biotechnology industry is in the same range as TPST (91) in the Pharmaceuticals Major industry. This means that PHIO’s stock grew similarly to TPST’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PHIOTPST
RSI
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
89%
Momentum
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 13 days ago
83%
Bullish Trend 7 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
80%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
PHIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TPST
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CCSI25.300.25
+1.00%
Consensus Cloud Solutions
ALL196.881.10
+0.56%
Allstate Corp (The)
ACA101.39-2.28
-2.20%
Arcosa
RVPH1.12-0.08
-7.02%
Reviva Pharmaceuticals Holdings
PHR18.04-2.96
-14.10%
Phreesia

PHIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHIO has been loosely correlated with MTNB. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if PHIO jumps, then MTNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHIO
1D Price
Change %
PHIO100%
-0.90%
MTNB - PHIO
50%
Loosely correlated
-2.27%
TPST - PHIO
49%
Loosely correlated
-8.27%
IMNN - PHIO
39%
Loosely correlated
-3.66%
MDWD - PHIO
35%
Loosely correlated
-2.26%
BCYC - PHIO
33%
Loosely correlated
-3.50%
More

TPST and

Correlation & Price change

A.I.dvisor indicates that over the last year, TPST has been loosely correlated with PHIO. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if TPST jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TPST
1D Price
Change %
TPST100%
-8.27%
PHIO - TPST
49%
Loosely correlated
-0.90%
ABCZF - TPST
48%
Loosely correlated
N/A
PMVP - TPST
41%
Loosely correlated
+0.62%
ATOS - TPST
32%
Poorly correlated
-6.57%
ORMP - TPST
30%
Poorly correlated
-4.50%
More